PRODUCT
Summary
LSD2 / AOF1 peptide is used for blocking the activity of LSD2 / AOF1 antibody (catalog number GTX32122). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37ºC.
APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
Assay dependent |
Not tested in other applications.
PROPERTIES
Form
Liquid
Buffer
PBS, 0.1% BSA
Preservative
0.02% Sodium azide
Storage
Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Concentration
200 μg/ml (Please refer to the vial label for the specific concentration.)
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
Lysine Demethylase 1B , Aof1 , C6Orf193 , Lsd2 , Ba204B7.3 , Dj298J15.2 , Kdm1B
Background
Flavin-dependent histone demethylases, such as KDM1B, regulate histone lysine methylation, an epigenetic mark that regulates gene expression and chromatin function (Karytinos et al., 2009 [PubMed 19407342]).[supplied by OMIM, Oct 2009]
Research Area
REFERENCE
There are currently no references for LSD2 / AOF1 blocking peptide (GTX32122-PEP). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for LSD2 / AOF1 blocking peptide (GTX32122-PEP). Be the first to share your experience with this product.